Corresponding Author: Carol M. Mangione, MD, MSPH, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Ste 700, Los Angeles, CA 90024 (email@example.com).
Accepted for Publication: September 1, 2022.
The US Preventive Services Task Force (USPSTF) Members: Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Cabana, MD, MA, MPH; Tumaini Rucker Coker, MD, MBA; Karina W. Davidson, PhD, MASc; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Carlos Roberto Jaén, MD, PhD, MS; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; John M. Ruiz, PhD; Michael Silverstein, MD, MPH; James Stevermer, MD, MSPH; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) Members: University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of North Carolina at Chapel Hill (Nicholson, Donahue); Albert Einstein College of Medicine, New York, New York (Cabana); University of Washington, Seattle (Coker); Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); The University of Texas Health Science Center, San Antonio (Jaén); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Chan Medical School, Worcester (Pbert); University of Arizona, Tucson (Ruiz); Brown University, Providence, Rhode Island (Silverstein); University of Missouri, Columbia (Stevermer); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Mangione had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Iris Mabry-Hernandez, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Published by JAMA®—Journal of the American Medical Association under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2022 AMA and United States Government, as represented by the Secretary of the Department of Health and Human Services (HHS), by assignment from the members of the United States Preventive Services Task Force (USPSTF). All rights reserved.
M , Wallace
I , Middleton
et al. Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents: An Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 221. Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05293-EF-1.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
M , Wallace
IF , Cook Middleton
et al. Screening for anxiety in children and adolescents: evidence report and systematic review for the US Preventive Services Task Force. JAMA
. Published October 11, 2022. doi:10.1001/jama.2022.16303Google Scholar
US Department of Commerce. 2020 National Survey of Children’s Health: Topical Frequencies. US Census Bureau; 2021.
JT , Santucci
LC , Weiner
CL . Separation anxiety disorder in youth: phenomenology, assessment, and treatment. Psicol Conductual
. 2008;16(3):389-412.PubMedGoogle Scholar
M , Neudorf
C , D’Arcy
C , Kunst
A , Warren
LM , Bennett
NR . A systematic review of depressed mood and anxiety by SES in youth aged 10-15 years. Can J Public Health
. 2008;99(2):125-129. doi:10.1007/BF03405459PubMedGoogle ScholarCrossref
K , Höfler
M , Gloster
et al. The structure of common mental disorders: a replication study in a community sample of adolescents and young adults. Int J Methods Psychiatr Res
. 2009;18(4):204-220. doi:10.1002/mpr.293PubMedGoogle ScholarCrossref
The Trevor Project. 2021 National Survey on LGBTQ Youth Mental Health. The Trevor Project; 2021.
DL , Calhoun
CD , Banks
DE , Halliday
CA , Hughes-Halbert
C , Danielson
CK . Making the “C-ACE” for a culturally-informed adverse childhood experiences framework to understand the pervasive mental health impact of racism on Black youth. J Child Adolesc Trauma
. 2020;14(2):233-247. doi:10.1007/s40653-020-00319-9PubMedGoogle ScholarCrossref
KR , He
JP , Burstein
et al. Service utilization for lifetime mental disorders in US adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry
. 2011;50(1):32-45. doi:10.1016/j.jaac.2010.10.006PubMedGoogle ScholarCrossref
Z , Whiteside
S , Sim
et al. Anxiety in Children. Comparative Effectiveness Review No. 192. Agency for Healthcare Research and Quality; 2017. AHRQ publication 17-EHC023-EF.
D , McIntosh
M . The role of primary care physicians in detection and treatment of adolescent mental health problems. In: Evans
DL , Foa
EB , Gur
RE , Hendin
H , O'Brien
CP , Romer
et al, eds. Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don't Know: A Research Agenda for Improving the Mental Health of Our Youth. 2nd ed. Oxford University Press; 2012.
US Preventive Services Task Force. Screening for depression and suicide risk in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA
. Published online October 11, 2022. doi:10.1001/jama.2022.16946Google Scholar
US Preventive Services Task Force. Primary care–based interventions to prevent illicit drug use in children, adolescents, and young adults: US Preventive Services Task Force recommendation statement. JAMA
. 2020;323(20):2060-2066. doi:10.1001/jama.2020.6774PubMedGoogle ScholarCrossref
US Preventive Services Task Force. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force recommendation statement. JAMA
. 2018;320(18):1899-1909. doi:10.1001/jama.2018.16789PubMedGoogle ScholarCrossref